These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 5088345)

  • 1. Vaccination and protection experiments in mice with the human A-1957 and A-1968 strains, and the Equi-2 strain of influenza virus.
    Masurel N; Baars AJ; Frankena H
    Antonie Van Leeuwenhoek; 1973; 39(3):461-71. PubMed ID: 4543055
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-protection in mice after immunization with H2N2, H3N2, and Heq2Neq2 influenza virus strains.
    Anker WJ; Bakker AK; Masurel N
    Infect Immun; 1978 Jul; 21(1):96-101. PubMed ID: 711325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunity tests with a Hong Kong strain influenza virus lethal to mice].
    Herzberg K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):298-303. PubMed ID: 5456375
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain.
    Sidorova LA; Alekseyeva AK
    Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies with the influenza virus strain A2 Moscow 57-65].
    Herzberg K; Reuss K
    Zentralbl Bakteriol Orig; 1968 Mar; 206(2):139-49. PubMed ID: 5707653
    [No Abstract]   [Full Text] [Related]  

  • 6. [Further studies on influenza-immunity by means of a mouse-lethal influenza virus strain A-Hong Kong. 3].
    Herzberg K
    Zentralbl Bakteriol Orig A; 1973 Feb; 223(2):173-9. PubMed ID: 4145873
    [No Abstract]   [Full Text] [Related]  

  • 7. The nature of the immunity evoked by infection of mice with avirulent influenza virus.
    Kurimura T; Hirano A; Okuno Y
    Biken J; 1972 Mar; 15(1):31-7. PubMed ID: 5055346
    [No Abstract]   [Full Text] [Related]  

  • 8. [Further immunity tests on a mouse-lethal influenza virus strain Hong Kong with reference to its subtype. II].
    Herzberg K
    Zentralbl Bakteriol Orig; 1971; 216(4):421-7. PubMed ID: 5088345
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a vaccine against pandemic influenza viruses: current status and perspectives.
    Ilyinskii PO; Thoidis G; Shneider AM
    Int Rev Immunol; 2008; 27(6):392-426. PubMed ID: 19065349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Β-defensins - Underestimated peptides in influenza combat.
    Kalenik BM; Góra-Sochacka A; Sirko A
    Virus Res; 2018 Mar; 247():10-14. PubMed ID: 29421304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of pregnancy on systemic immunity.
    Pazos M; Sperling RS; Moran TM; Kraus TA
    Immunol Res; 2012 Dec; 54(1-3):254-61. PubMed ID: 22447351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theoretical considerations on the natural variability of influenza virus].
    Moisa I
    Stud Cercet Inframicrobiol; 1969; 20(5):413-24. PubMed ID: 4906010
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.